Telzuit Medical Technologies, Inc. (fka TZMT)

[goodlive]

I did ask the company.
That's the answers:

"The remaining "fine tuning" will not be an extended period."

"The PR does show progress in rolling some product out to the market and also shows that even though the product may not be fine tuned, doctors are still willing to pay for it over conventional Holter systems."

I think that's good enough for me.
If they would play false they could have concealed the problem.